C. Ordu Et Al. , "Anti-mullerian hormone (AMH) levels and antral follicle counts (AFC) may predict ovarian reserves before systemic chemotherapy (SC) in women with breast cancer (BC): A prospective clinical study," 44th Congress of the European-Society-for-Medical-Oncology (ESMO) , vol.30, Barcelona, Spain, pp.85-86, 2019
Ordu, C. Et Al. 2019. Anti-mullerian hormone (AMH) levels and antral follicle counts (AFC) may predict ovarian reserves before systemic chemotherapy (SC) in women with breast cancer (BC): A prospective clinical study. 44th Congress of the European-Society-for-Medical-Oncology (ESMO) , (Barcelona, Spain), 85-86.
Ordu, C., Gachayev, F., Elbuken, F., Baysal, B., Pilanci, K. N., Alco, G., ... Ilgun, A. S.(2019). Anti-mullerian hormone (AMH) levels and antral follicle counts (AFC) may predict ovarian reserves before systemic chemotherapy (SC) in women with breast cancer (BC): A prospective clinical study . 44th Congress of the European-Society-for-Medical-Oncology (ESMO) (pp.85-86). Barcelona, Spain
Ordu, C. Et Al. "Anti-mullerian hormone (AMH) levels and antral follicle counts (AFC) may predict ovarian reserves before systemic chemotherapy (SC) in women with breast cancer (BC): A prospective clinical study," 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 2019
Ordu, C. Et Al. "Anti-mullerian hormone (AMH) levels and antral follicle counts (AFC) may predict ovarian reserves before systemic chemotherapy (SC) in women with breast cancer (BC): A prospective clinical study." 44th Congress of the European-Society-for-Medical-Oncology (ESMO) , Barcelona, Spain, pp.85-86, 2019
Ordu, C. Et Al. (2019) . "Anti-mullerian hormone (AMH) levels and antral follicle counts (AFC) may predict ovarian reserves before systemic chemotherapy (SC) in women with breast cancer (BC): A prospective clinical study." 44th Congress of the European-Society-for-Medical-Oncology (ESMO) , Barcelona, Spain, pp.85-86.
@conferencepaper{conferencepaper, author={C. Ordu Et Al. }, title={Anti-mullerian hormone (AMH) levels and antral follicle counts (AFC) may predict ovarian reserves before systemic chemotherapy (SC) in women with breast cancer (BC): A prospective clinical study}, congress name={44th Congress of the European-Society-for-Medical-Oncology (ESMO)}, city={Barcelona}, country={Spain}, year={2019}, pages={85-86} }